Rockefeller Capital Management
TAK icon

Rockefeller Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Rockefeller Capital Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375K Buy
20,250
+15,066
+291% +$264K ﹤0.01% 2138
2025
Q4 		$80.8K Buy
5,184
+1,215
+31% +$17.4K ﹤0.01% 2817
2025
Q3 		$58.1K Buy
+3,969
New +$58.9K ﹤0.01% 2830
2024
Q2 		– Sell
-104,543
Closed -$1.45M – 1729
2024
Q1 		$1.45M Buy
+104,543
New +$1.52M ﹤0.01% 1132
2023
Q1 		– Sell
-2,515
Closed -$37K – 3683
2022
Q4 		$37K Sell
2,515
-610
-20% -$8.52K ﹤0.01% 2537
2022
Q3 		$38K Sell
3,125
-38
-1% -$528 ﹤0.01% 2492
2022
Q2 		$43K Sell
3,163
-5,319
-63% -$75.9K ﹤0.01% 2359
2022
Q1 		$119K Buy
8,482
+5,915
+230% +$86.8K ﹤0.01% 1911
2021
Q4 		$33K Sell
2,567
-813
-24% -$11.4K ﹤0.01% 2403
2021
Q3 		$54K Buy
3,380
+671
+25% +$11.3K ﹤0.01% 2107
2021
Q2 		$45K Buy
2,709
+140
+5% +$2.38K ﹤0.01% 2131
2021
Q1 		$46K Buy
2,569
+598
+30% +$10.8K ﹤0.01% 1923
2020
Q4 		$35K Sell
1,971
-712
-27% -$12.5K ﹤0.01% 1799
2020
Q3 		$47K Buy
2,683
+624
+30% +$11.4K ﹤0.01% 1525
2020
Q2 		$37K Sell
2,059
-555
-21% -$9.96K ﹤0.01% 1492
2020
Q1 		$40K Sell
2,614
-15,454
-86% -$280K ﹤0.01% 1303
2019
Q4 		$357K Sell
18,068
-982
-5% -$18.8K ﹤0.01% 637
2019
Q3 		$327K Buy
19,050
+539
+3% +$9.32K ﹤0.01% 539
2019
Q2 		$328K Sell
18,511
-41,176
-69% -$749K ﹤0.01% 505
2019
Q1 		$1.22M Buy
+59,687
New +$1.2M 0.02% 343

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rockefeller Capital Management's TAK Position: Q1 2026 in Review

Rockefeller Capital Management increased its Takeda Pharmaceutical (TAK) stake by 291% in Q1 2026, buying an estimated $264K and bringing the position to 20,250 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

Rockefeller Capital Management first reported a position in TAK in Q1 2019 and has held it in 20 quarters since. The position peaked at $1.45M in Q1 2024. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Rockefeller Capital Management held 20,250 shares of Takeda Pharmaceutical worth $375K as of Q1 2026.
  • Rockefeller Capital Management bought 15,066 Takeda Pharmaceutical shares in Q1 2026, an estimated $264K.
  • Takeda Pharmaceutical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #2138 holding.
  • Rockefeller Capital Management first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 20 quarters since.
  • Rockefeller Capital Management's Takeda Pharmaceutical position peaked at $1.45M in Q1 2024.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.